SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-057284
Filing Date
2015-09-28
Accepted
2015-09-29 23:12:54
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v420245_10k.htm 10-K 759944
2 EXHIBIT 21.1 v420245_ex21-1.htm EX-21.1 2507
3 EXHIBIT 31.1 v420245_ex31-1.htm EX-31.1 15287
4 EXHIBIT 31.2 v420245_ex31-2.htm EX-31.2 10756
5 EXHIBIT 32.1 v420245_ex32-1.htm EX-32.1 5883
6 EXHIBIT 32.2 v420245_ex32-2.htm EX-32.2 5934
  Complete submission text file 0001144204-15-057284.txt   5102160

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT antb-20150630.xml EX-101.INS 878521
8 XBRL TAXONOMY EXTENSION SCHEMA antb-20150630.xsd EX-101.SCH 56661
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20150630_cal.xml EX-101.CAL 50871
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20150630_def.xml EX-101.DEF 357856
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20150630_lab.xml EX-101.LAB 420702
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20150630_pre.xml EX-101.PRE 405971
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54495 | Film No.: 151132116
SIC: 2834 Pharmaceutical Preparations